SUMMARY Parvovirus B19 (B19V) and human bocavirus 1 (HBoV1), members of the large
Parvoviridae family, are human pathogens responsible for a variety of diseases. For B19V in …

Pure red cell aplasia (PRCA) is a syndrome defined by a normocytic normochromic anemia
with severe reticulocytopenia and marked reduction or absence of erythroid precursors from …

Skin disease due to viruses may be a primary infection of the epidermis or may arise
secondary to systemic infection. Depending on the virus, the effects may be necrotic damage …

SUMMARY Parvovirus B19 (B19) was discovered in 1974 and is the only member of the
family Parvoviridae known to be pathogenic in humans. Despite the inability to propagate …

Parvovirus B19 is the cause of fifth disease in children and can trigger transient arthropathy
in adults. It can also provoke transient aplastic crises in patients with sickle cell disease or …

The pathogenic human parvovirus B19 replicates only in erythroid progenitor cells. This
virus was shown to bind to blood-group P antigen, as measured by hemagglutination …

Antibody-based therapies are currently undergoing a renaissance. After being developed
and then largely abandoned in the twentieth century, many antibody preparations are now in …

Antibodies have been used for over a century in the prevention and treatment of infectious
disease. They are used most commonly for the prevention of measles, hepatitis A, hepatitis …

SARS-CoV-2 is a novel β-coronavirus that caused the COVID-19 pandemic disease, which
spread rapidly, infecting more than 134 million people, and killing almost 2.9 million thus far …

In the preantibiotic era, passive antibody administration (serum therapy) was useful for the
treatment of many infectious diseases. The introduction of antimicrobial chemotherapy in the …